Skip to main content

Table 2 Stimulation procedures and outcomes for astrocyte monocultures

From: Human iPSC-derived glia models for the study of neuroinflammation

Stimulus

Stimulus concentration

Stimulus time

Method

Measure of inflammation

References

TNF

10 ng/mL

24 h

RT-qPCR

Increased IL8, IL1B, IFNG, TNF, IL2, IL4, IL6, IL10

[88]

Cytometric bead array

Increased IL-8, IL-1β, IFN-γ, TNF, IL-2, IL-4, IL-6, IL-10

[91]

48 h

Cytometric bead array

Increased IL-8

[91]

5 days

Bulk RNA sequencing

Increased IL6, C3, CXCL10, CXCL11 amongst others

[92]

Immunostaining

Increased GFAP intensity

[88]

Multiplex bead-based immunoassays

Increased GM-CSF, IL-1β

[94]

30 ng/mL

7 days

Western Blot

Increased NF-κB phosphorylation

[90]

50 ng/mL

1.5 h

Immunostaining

Increased NF-κB nuclear translocation

[88]

5 h

Flow cytometry

Increased IL-8 and IL-6

[89]

24 h

Cytometric bead array

Increased IL-8

[91]

48 h

Cytometric bead array

Increased IL-8

[91]

48 h

RT-qPCR

Increased CCL5, CXCL8

[93]

7 days

Western blot

No change in GFAP expression

[93]

ELISA

Increased IL-6

[93]

100 ng/mL

7 days

Bulk RNA sequencing

Increased IL8, C3, CXCL10 and CXCL11 amongst others

[90]

Western Blot

Increased NF-κB phosphorylation

[90]

IL-1β

10 ng/mL

5 h

Bulk RNA sequencing

Enrichment for inflammation-related GO terms

[89]

5 h

Flow cytometry

Increased IL-6 and IL-8

[89]

24 h

Cytometric bead array

Increased IL-8

[91]

48 h

Cytometric bead array

Increased IL-8

[91]

48 h

RT-qPCR

Increased CCL5, CXCL8

[93]

5 days

Multiplex bead-based immunoassays

Increased IL-6, GM-CSF, TNF, IL-23, IFN-β, IFN-α

[94]

7 days

Western Blot

Increased GFAP expression

[93]

ELISA

Increased IL-6

[93]

100 ng/mL

7 days

Bulk RNA sequencing

Increased IL8, C3, CXCL10 and CXCL11 amongst others

[90]

Western Blot

No change in NF-κB phosphorylation

[90]

TNF and IL-1β

10 ng/mL TNF and 10 ng/mL IL-1β

1 h

RT-qPCR

Decreased GFAP

[96]

Western blot

Decreased GFAP

[96]

Immunostaining

Increased NF-κB nuclear translocation

[96]

5 days

Multiplex bead-based immunoassays

Increased GM-CSF, TNF, IL-1α, IL-6, IL-10, IL-12, IL-23, IFN-β, IFN-α

[94]

7 days

RT-qPCR

Increased CCL5, CXCL8, C3, LCN2

[96]

ELISA

Increased IL-6

[96]

24 h

Multiplex bead-based immunoassays

Increased C3a, MCP-3, I-TAC, GRO-a, sICAM-1, GM-CSF, IL-1RA, MIG, RANTES, IL-6, MCP-2, MIP-1a

[98]

IL-1α, TNF, and C1q

3 ng/mL IL-1α, 30 ng/mL TNF, and 400 ng/mL C1q

24 h

Multiplex bead-based immunoassays

Increased C3a, MCP-3, I-TAC, GRO-a, sICAM-1, GM-CSF, MIG, RANTES, IL-6, MCP-2, MIP-1a

[98]

Western blot

No change in GFAP

[98]

RT-qPCR

Increased TNF and IL-1β, decreased GFAP

[97]

Whole proteome analysis

Enrichment of GO-terms related to immune responses, cytokine-associated signalling, and recruitment of peripheral immune cells following treatment

[147]

Amyloid-beta fibrils

(Aβ-F)

0.2 µM

24 h

Cytokine array

Measured 36 human chemokines and cytokines, no change detected

[79]

α-Synuclein fibrils (αSYN-F)

0.5 µM

24 h

Cytokine array

Measured 36 human chemokines and cytokines, no change detected

[79]